A couple requested preimplantation genetic analysis for a dominant form of retinitis pigmentosum caused by a C→A transversion in the rhodopsin gene. Since this point mutation does not alter a restriction endonuclease site we designed two separate analytical systems, one involving site-specific mutagenesis and the other involving allele-dependent length polymorphism. After establishing the accuracy and robustness of these assay systems we utilized both systems simultaneously in a heminested polymerase chain reaction (PCR) system. This allowed accurate preimplantation diagnosis to be performed. One embryo was transferred but a pregnancy did not occur.
Introduction
Preimplantation genetic diagnosis (PGD) was developed for couples at high genetic risk to avoid affected pregnancies and the potential for pregnancy termination following prenatal diagnosis. The first successful application of PGD involved removal of one cell from 5-8-cell embryos for gender determination for women who were carriers of X-linked diseases. This allowed transfer of female embryos who could not be affected with an X-linked disorder (Handyside et al., 1990; Verlinsky et al., 1996) . Specific mutation analysis by PGD was successfully performed to screen oocytes and pre-embryos for cystic fibrosis (CF) (Strom et al., 1990; Handyside et al., 1992) . Our centre has been involved in developing PGD using analysis of polar bodies (PB) in addition to embryo biopsy (Strom et al., 1990 (Strom et al., , 1992 (Strom et al., , 1994 Rechitsky et al., 1996) . The first polar body (PB1) is extruded following meiosis I. There are three genetic possibilities for the first polar body from a heterozygous woman. If no crossing over occurs, PB1 will be homozygous (either normal or affected), but in the event of a crossover PB1 will be heterozygous. If crossover does not occur and PB1 is homozygous for the mutant gene, the oocyte must contain two copies of the normal gene and any embryo developing from this oocyte can be transferred without risk of an affected child. If the PB1 is homozygous for the normal gene, the maternal contribution to any embryo must be the mutant gene. In the event that crossover occurs, the PB1 will be heterozygous and analysis of either the second polar body (PB2) or a blastomere is required to predict which maternal allele will be present in the mature oocyte.
Retinitis pigmentosum (RP) is a heterogeneous genetic disease causing progressive vision loss. A point mutation in the rhodopsin gene on chromosome 7 has been demonstrated to cause many cases of autosomal dominant RP (Nathans and Hogness, 1984; Dryja et al., 1990) . A couple presented to our centre with a family history of the dominant form of RP due to this point mutation. The woman was affected and was suffering from deteriorating vision. They requested preimplantation genetic diagnosis (PGD).
PGD for Mendelian traits requires amplification of the gene using nested polymerase chain reaction (PCR). Since the mutation does not alter a restriction endonuclease site, we developed and tested two separate assays using published techniques for this point mutation. One method, site-specific mutagenesis (SSM), involves synthesis of PCR primers creating an artificial restriction site. The second method called alleledependent length polymorphism (ADLP), employs allelespecific primers for the mutant and normal sequence in which tails of different lengths are added to each primer. Both assays could successfully genotype single fibroblasts, but sometimes one assay would give clearer differentiation between the two alleles than the other.
Both assays use nested PCR with identical conditions for the first round of PCR. Thus we were able to perform both assays simultaneously on the same single cell in order to increase the accuracy of diagnosis.
Materials and methods

Patients
A couple requested PGD for a dominant form of RP. The woman was affected as was her father. Previous analysis had established that she was heterozygous for the C→A transversion in codon 23 of the rhodopsin gene demonstrated to be associated with RP by Dryja et al. (1990) . Family studies performed by another centre had confirmed that the disease segregated with this point mutation.
All protocols and consent forms were approved by the Institutional Review Board of Illinois Masonic Medical Center, IL, USA. Micromanipulation and in-vitro fertilization (IVF) were performed as described in detail elsewhere (Verlinsky et al., 1992 Strom et al., 1994) .
Polymerase chain reaction
Three pairs of primer sets were designed to assay codon 23 of the rhodopsin gene using the published sequence of the rhodopsin gene (Nathans and Hogness, 1984) . RP-1 and RP-2 are the outside primers and amplify a 558 bp region including codon 23 (see Figure 1 ). The sequence of RP-1 is (5Ј-3Ј) AGCTCAGGCCTTCGCAGCAT and RP-2 is (5Ј-3Ј) GAGGGCTTTGGATAACATTG. Following the first round of PCR, two different assays were developed for the C→A transversion, one using SSM and a second using ADLP.
Site-specific mutagenesis
The RP and normal rhodopsin gene sequences surrounding codon 23 are shown in Figure 2 . Unfortunately, no restriction endonuclease site is created or destroyed by the mutation. We designed a primer (RP-RS) with a single alteration from the normal sequence (an A→G transversion in the penultimate 5Ј nucleotide) that creates a restriction site for the enzyme Mne1 in the normal allele. The RP allele lacks the Mne1 site. This primer design is shown in Figure 1 . Following 20 rounds of amplification with the outside primers, 10 µl of a 100 µl reaction mixture were added to fresh buffer and the inside primer RP-RS was added along with RP1 to form a heminested PCR system. An additional 20 rounds of amplification were performed and the resulting PCR products were subjected to a 1-3 h restriction digestion with Mne1. The normal allele yielded a 139 bp band and the RP allele yielded a 156 bp band. These bands could be distinguished easily on ethidium bromide-stained polyacrylamide gels.
Allele-dependent length polymorphism
Following the same first round of amplification, a second 10 µl aliquot was removed and subjected to ADLP analysis. The primers for this analysis are shown in Figure 3 . In ADLP, two allele-specific primers were designed with the most 5Ј nucleotide corresponding to the transversion site. The RP specific primer has the identical sequence to the RP gene and the normal primer has the exact sequence of the normal allele. A run of non-specific nucleotides is added to the 3Ј ends of both primers. The lengths of the runs differ for each primer. In our design the RP primer (RP-RM) has a 20 bp tail and the normal primer has a 35 bp tail. This is illustrated in Figure 3 .
Thus priming of the normal gene yields a 147 bp product whereas priming of the RP gene gives a 132 bp product. These could be distinguished easily on polyacrylamide gels.
Results
A skin biopsy was taken from the affected woman and cultures of skin fibroblasts established. In a blinded fashion, single fibroblasts from this patient or a normal control were harvested by micro manipulation and analysed by the molecular laboratory. In all, 177 cells were analysed using the heminested simultaneous ADLP and SSM assays. Table I shows a summary of these analyses.
There were no diagnostic errors in this series. It is important to note that allele drop out (ADO), a phenomenon in single cell analysis where only one allele is amplified in a heterozygous cell was not seen. As others have noted, ADO is less common in fibroblast analysis than in polar body and blastomere analysis. In all cases where amplification failure occurred, both the ADLP and SSM assays failed to yield amplified product. This observation is not unexpected as the same first round of PCR is used for both reactions prior to aliquotting the samples prior to the second round of amplification. Another interesting observation was made during this series. For some experiments the ADLP analysis gave clearer results than the SSM analyses and for other experiments the converse was true, although there were no instances when the two methods gave conflicting results.
Confident that our system was sufficiently robust and accurate, we proceeded to perform a PGD analysis for this couple. Following stimulation, 11 oocytes were aspirated and nine first polar bodies were successfully removed for amplification. The remaining two oocytes were fragmented and not suitable for insemination or analysis.
Figures 4 and 5 show the results of the SSM assay for this case. Figure 4 , lanes 1 and 3, represents a single fibroblast control known to be homozygous unaffected (N/N). Lane 1 is Since all false biopsies and reagent controls were negative these faint bands are unlikely to be due to contamination. Due to the unambiguous results from the same polar bodies from the SSP analysis we were confident in our determinations of the genotypes of these polar bodies.
Similarly, polar body number 5 shown in lane 9 has a dark band at 132 bp and a faint band at 147 bp while the SSM assay revealed the cell to be homozygous affected. Lane 10 is a known heterozygous control but the 147 bp band is clearly darker than the 132 bp band. Thus, in this particular analysis the SSM was more easily interpreted than the ADLP. However, this is not always the case. Table II is a summary of the PGD analysis in this case. Two oocytes had a first polar body homozygous for the RP mutation meaning that the oocyte contained the normal allele. Only one of these oocytes fertilized and was transferred. A pregnancy did not develop. The unfertilized oocyte was analysed but did not reveal any amplification product.
Four oocytes had homozygous normal first polar bodies predicting that the oocyte would contain the affected gene. Since RP is a dominant disease in this family, any embryos resulting from these eggs would be affected. The four resulting embryos were dissociated into individual blastomeres and analysed to confirm the diagnosis. In all, 14 blastomeres from three embryos were successfully analysed and the affected status was confirmed in all cases.
Discussion
Point mutations that do not alter a restriction site provide challenges to accurate genotyping, especially in the context of single cell analysis. Several techniques such as allele-specific oligonucleotide hybridization, ADLP (initially called ARMS), SSM, and ligation PCR can be used in such situations. These assays, when used alone, can yield ambiguous results because of the sensitivity of each system to minor changes in reaction conditions. We specifically chose ADLP and SSP because they involved different mechanisms of specificity with ADLP relying on allele specific priming and SSP using the same priming sequences but with a primer mismatch. We felt that for any given reaction, if one assay failed, the other would succeed. Additional independent assays, such as SnuPE or SSCP could also have been used. We chose SSP and ADLP because we had the most experience with such assays, but there is no reason why all four assays could not be used simultaneously. Another potential method for increasing accuracy would be to perform replicate amplifications in the second round. This could potentially further reduce any ambiguity of results. However, we felt that the two assays, as currently performed, yielded accurate genotyping of single cells without the additional labour and time that these amendments would entail. This report demonstrates the successful application of a new technique for PGD of Mendelian disorders caused by point mutations that do not alter restriction sites. The simultaneous use of two assays using the same outside primer pair allows genotyping to be made with confidence, especially when using assays that rely on allele-specific priming or SSM. This technique, however, does not prevent or detect allele drop out. Another multiplexed outside primer pair looking at a linked polymorphism would have the ability to detect this phenomenon.
The ADLP assay sometimes gave ambiguous results apparently due to non-specific priming. The SSM assay sometimes yielded insufficient PCR product for unambiguous genotyping presumably due to inefficient priming by the mismatched primer. Since the two assays fail for different reasons, in any single analysis, at least one assay should succeed.
In the case of an autosomal dominant disease when the female has the affected gene, polar body diagnosis is far preferable to blastomere biopsy. We have observed a 3-fold higher rate of ADO in blastomeres than in polar bodies (unpublished data). and have also observed high rates of ADO in blastomere analysis for cystic fibrosis even after conditions have been optimized. If ADO occurs following a blastomere biopsy in a dominant disease, an affected embryo could be misdiagnosed as unaffected. This situation is analogous to performing blastomere biopsy for a recessive disease when the parents have different mutations. In such cases, ADO has led to misdiagnoses in three cases of cystic fibrosis (Handyside and Delhanty, 1996; Lissens and Sermon, 1997 ). An excellent review of this issue can be found in Lissens and Sermon (1997) . Therefore we do not offer PGD by blastomere analysis for dominant diseases or for recessive diseases (both autosomal and Xlinked) when the parents have different mutations.
We feel that the use of two assays increases the accuracy of single cell genetic diagnosis, but could also be used in standard genotyping applications such as prenatal diagnosis, diagnostic testing and carrier detection.
